Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung
衰老肺内皮再生的新信号传导和分子靶点
基本信息
- 批准号:9307973
- 负责人:
- 金额:$ 39.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2017-09-01
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAddressAdult Respiratory Distress SyndromeAgingAnimal ModelAnimalsBlood VesselsCXCR4 ReceptorsCXCR4 geneCellsComplexDataEdemaElderlyEndotheliumExtravasationFOXM1 geneFluid BalanceG-Protein-Coupled ReceptorsGoalsHomeostasisHumanHypoxemiaHypoxia Inducible FactorImpairmentIncidenceInfiltrationInflammatoryInjuryLigationLungLung InflammationMediator of activation proteinMolecularMolecular TargetMusNatural regenerationOutcomeOxygenPathogenicityPathway interactionsPatientsPharmacologyProcollagen-Proline DioxygenaseProtein IsoformsProteinsPulmonary EdemaPuncture procedureRecoveryResolutionRoleSecondary toSepsisSeveritiesSignal TransductionSyndromeTherapeuticTranscriptional RegulationTreatment EfficacyUrsidae FamilyVascular Endothelial CellVascular Permeabilitiesagedclinically relevantforkhead proteinimprovedlung injurylung vascular injurymortalitynovelnovel therapeutic interventionnovel therapeuticsolder patientprogramspublic health relevancerepairedrestorationsensortherapeutic target
项目摘要
DESCRIPTION (provided by applicant): An essential component of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is that injury of the endothelial barrier of pulmonary microvessels results in persistent increase in lung vascular permeability to protein and intractable protein-rich edema formation. Compared to young patients, the incidence of ALI/ARDS resulting from sepsis in elderly patients is as much as 19-fold greater and the mortality rate is up to 10-fold greater. However, the underlying causes are poorly understood. Also crucially little is known how aging influences mechanisms of endothelial regeneration and restoration of vascular homeostasis following sepsis challenge. We have recently shown that the Forkhead transcription factor FoxM1 is a key reparative factor responsible for endothelial regeneration. However, our new Supporting Data presented here show that FoxM1 expression and the endogenous endothelial regeneration program were severely impaired in aged lungs following inflammatory lung injury. We observed that endothelial hypoxia-inducible factor HIF-1α is the critical mediator of FoxM1 expression through transcriptional control of SDF-1α which activates CXCR4 receptor leading to activation of the GPCR-dependent p110gamma isoform of PI3K, and that inhibition of the oxygen sensors HIF prolyl hydroxylase (PHDs) re-induced FoxM1 expression and activated the endothelial regeneration program in aged lungs. Thus, we hypothesize that impaired HIF- 1α->FoxM1 signaling secondary to activation of PHD2 in aged lungs is responsible for the severely defective endothelial regeneration in these lungs, and activation of this fundamental reparative pathway through PHD2 inhibition and CXCR4 activation is a potential novel therapeutic approach for reversing lung microvessel leakiness and improving survival of elderly ALI/ARDS patients. The proposed studies address the following Specific Aims. In Aim #1, we will address the role of impaired HIF-1α->FoxM1 signaling in aged lungs as a crucial factor responsible for severely impaired endothelial regeneration and restoration of lung vascular homeostasis following sepsis challenge. In Aim #2, we will delineate the signaling mechanisms underlying severely defective endothelial regeneration in aged lungs following sepsis challenge. In Aim #3, we will determine the role of HIF-1α stabilization through PHD inhibition in activating endothelial regeneration in aged lungs. We will also address the potential clinical relevance of our findings in animal models to humans; thereby determine the therapeutic implications of inhibition of PHD2 and activation of CXCR4 in treatment of ALI/ARDS of elderly patients. With these comprehensive studies, we will delineate the fundamental signaling mechanisms of impaired endothelial regeneration in aged lungs, and identify therapeutic targets to activate this fundamental intrinsic HIF-1α->FoxM1-dependent mechanisms to repair leaky lung microvessels for the treatment of ALI/ARDS in elderly patients.
描述(由申请人提供):急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的一个重要组成部分是肺微血管内皮屏障的损伤导致肺血管对蛋白质的通透性持续增加和难治性富含蛋白质的水肿形成。与年轻患者相比,老年患者败血症导致的ALI/ARDS发生率高达19倍,死亡率高达10倍。然而,人们对其根本原因知之甚少。同样至关重要的是,我们对衰老如何影响脓毒症后内皮细胞再生和血管稳态恢复的机制知之甚少。我们最近发现叉头转录因子FoxM1是内皮细胞再生的关键修复因子。然而,我们在这里提出的新的支持数据显示,在炎症性肺损伤后的老年肺中,FoxM1的表达和内源性内皮再生程序严重受损。我们观察到内皮缺氧诱导因子HIF-1α是FoxM1表达的关键介质,通过转录控制SDF-1α激活CXCR4受体,导致gpcr依赖的PI3K p110gamma亚型的激活,抑制氧传感器HIF脯氨酰羟化酶(PHDs)重新诱导FoxM1表达并激活老化肺内皮再生程序。因此,我们假设老年肺中继发于PHD2激活的HIF- 1α->FoxM1信号受损是导致这些肺内皮再生严重缺陷的原因,通过抑制PHD2和激活CXCR4激活这一基本修复途径是逆转肺微血管渗漏和提高老年ALI/ARDS患者生存率的潜在新治疗方法。建议的研究涉及以下具体目标。在Aim #1中,我们将研究HIF-1α->FoxM1信号受损在老年肺部中的作用,这是脓毒症挑战后内皮再生和肺血管稳态恢复严重受损的关键因素。在Aim #2中,我们将描述脓毒症挑战后老年肺部严重缺陷的内皮再生的信号机制。在Aim #3中,我们将通过PHD抑制来确定HIF-1α稳定在激活老年肺内皮细胞再生中的作用。我们还将讨论我们在动物模型中的发现与人类的潜在临床相关性;从而确定抑制PHD2和激活CXCR4在治疗老年ALI/ARDS患者中的治疗意义。通过这些综合研究,我们将描述衰老肺部内皮细胞再生受损的基本信号机制,并确定激活这种基本的内在HIF-1α-> foxm1依赖机制来修复肺微血管渗漏的治疗靶点,以治疗老年ALI/ARDS患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOU-YANG ZHAO其他文献
YOU-YANG ZHAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOU-YANG ZHAO', 18)}}的其他基金
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH
RNA修饰在肺血管重塑和PAH发病机制中的新作用
- 批准号:
10540134 - 财政年份:2022
- 资助金额:
$ 39.88万 - 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
- 批准号:
10467781 - 财政年份:2022
- 资助金额:
$ 39.88万 - 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
- 批准号:
10629328 - 财政年份:2022
- 资助金额:
$ 39.88万 - 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
- 批准号:
10434658 - 财政年份:2020
- 资助金额:
$ 39.88万 - 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
- 批准号:
10618326 - 财政年份:2020
- 资助金额:
$ 39.88万 - 项目类别:
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension
靶向平滑肌祖细胞治疗肺动脉高压
- 批准号:
10189689 - 财政年份:2018
- 资助金额:
$ 39.88万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10470871 - 财政年份:2016
- 资助金额:
$ 39.88万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10316765 - 财政年份:2016
- 资助金额:
$ 39.88万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10677597 - 财政年份:2016
- 资助金额:
$ 39.88万 - 项目类别:
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung
衰老肺内皮再生的新信号传导和分子靶点
- 批准号:
8909182 - 财政年份:2014
- 资助金额:
$ 39.88万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.88万 - 项目类别:
Research Grant














{{item.name}}会员




